Accenture Federal Services (AFS) recently announced its acquisition of ASM Research, Inc. The acquisition will expand Accenture’s capabilities and opportunities with the Department of Defense (DoD) and Veterans Affairs (VA) and ASM Research will become a wholly owned subsidiary of AFS.
KippsDeSanto advised ASM Research on the transaction.
“I’ve served at ASM Research for more than 30 years helping to build this great company. We needed the right partner to take us to the next stage in our growth and Accenture was the perfect choice because of its shared commitment to both employees and clients,” said Jeri Lassiter, CEO of ASM Research. “Accenture stands out among systems integrators in its ability to deliver important and complex mission solutions across the enterprise and we’re excited to join forces to make a difference for our clients and our people.”
Based in Fairfax, Va., ASM Research is an employee-owned company with three decades of government experience and expertise in a multitude of fields including healthcare IT, information solutions and services, data analytics, cloud, data warehousing, human capital management and benefit solutions and agile software development.
“ASM Research has strong U.S. military and federal health credentials, a success-oriented culture, extremely talented and committed people and a rich technology portfolio backed by decades of mission expertise,” said said David Moskovitz, chief executive at Accenture Federal Services. “Acquiring the company will expand the offerings and value we provide to DoD and position us to deliver our compelling clinical, benefits and business solutions to federal health agencies going through a once-in-a-generation modernization.”
Moskovitz also revealed that Jim Traficant, Managing Director at AFS, will lead the new subsidiary company. “His personal conviction and decades of government, defense and healthcare experience make him uniquely qualified for this critical position,” added Moskovitz.
Steve Rohleder, Group Chief Executive who leads Accenture’s Health & Public Service operating group commented on the acquisition, saying “This strategic acquisition will expand our U.S. federal health capabilities, serving the needs of military personnel and veterans, and will help us better support clients in our growing health business across North America.”